Trending...
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Cancer Survivor Roslyn Franken Marks 30-Year Milestone with Empowering Gift for Women Survivors
- Sink Better with the Green Sink Initiative
Western Australian researchers have discovered the genetic cause of a rare muscle disease that causes muscle weakness, droopy eyelids and difficulty swallowing.
NEDLANDS, Australia - AussieJournal -- Researchers at the Harry Perkins Institute of Medical Research and The University of Western Australia (UWA) have discovered the genetic cause of a rare muscle disease that causes muscle weakness, droopy eyelids and difficulty swallowing.
The disease, known as oculopharyngodistal myopathy (OPDM), is an inherited muscle disease. Genes associated with OPDM had only been identified previously in Asian populations.
This week, Perkins researchers in the Rare Disease Genetics and Functional Genomics Group (https://perkins.org.au/research/labs/genome-bio...), led by Associate Professor Gina Ravenscroft (https://perkins.org.au/person/gina-ravenscroft-2/), and the Preventative Genetics Group (https://perkins.org.au/research/labs/genome-bio...), led by Emeritus Professor Nigel Laing AO, published findings from an international world-leading study that identified the genetic cause of OPDM in people of European descent.
More on Aussie Journal
The researchers discovered that a specific type of mutation, an expansion of a repeat sequence, in the ABCD3 gene triggers a cascade of cellular issues that ultimately leads to muscle degeneration. These repeat expansions have been difficult to pinpoint, but new technologies and computer tools have enabled researchers to more easily find these repeat expansions that cause disease.
"It is so important to study genetic variations across different populations. Discovering that the ABCD3 gene was the cause of OPDM in Europeans adds to the understanding of this disease and opens the door for researchers to explore potential treatments for this and similar muscle diseases," Associate Professor Gina Ravenscroft said.
"Identifying disease-causing genes for families is so rewarding, often families experience these life-changing symptoms and many never get answers about the cause of their disorder. For some families this has ended a very long diagnostic odyssey, with DNA samples first received almost 30 years ago."
There are more than 10,000 distinct rare diseases, 70% of which start in childhood. Most of these diseases have a genetic origin, and families must rely on medical researchers to find the disease-gene needle in their DNA haystack.
More on Aussie Journal
"Rare diseases impact around 1 in 10 people and these families can go a lifetime without answers. By finding the genetic cause, we can give families a better understanding of the disease progression, their likelihood of passing it on, and importantly it offers the possibility of finding new treatments or cures one day," Associate Professor Ravenscroft said.
The study was published this week in Nature Communications. (https://www.nature.com/articles/s41467-024-49950-2)
The disease, known as oculopharyngodistal myopathy (OPDM), is an inherited muscle disease. Genes associated with OPDM had only been identified previously in Asian populations.
This week, Perkins researchers in the Rare Disease Genetics and Functional Genomics Group (https://perkins.org.au/research/labs/genome-bio...), led by Associate Professor Gina Ravenscroft (https://perkins.org.au/person/gina-ravenscroft-2/), and the Preventative Genetics Group (https://perkins.org.au/research/labs/genome-bio...), led by Emeritus Professor Nigel Laing AO, published findings from an international world-leading study that identified the genetic cause of OPDM in people of European descent.
More on Aussie Journal
- From Tech Neck to Chronic Pain: Women's Health at Work
- Zero-Trust Architecture: NJTRX Addresses 60% of U.S. Investors' Custody Security Concerns
- Sub-Millisecond Trading Platform: HNZLLQ Introduces Unified Gateway for Philippine Digital Asset Traders
- $2.1B Theft Losses: Bitquore Launches 1M+ TPS Platform with 95% Offline Asset Protection for U.S. Traders
- America Anesthesia Partners Unveils New User-Friendly Website
The researchers discovered that a specific type of mutation, an expansion of a repeat sequence, in the ABCD3 gene triggers a cascade of cellular issues that ultimately leads to muscle degeneration. These repeat expansions have been difficult to pinpoint, but new technologies and computer tools have enabled researchers to more easily find these repeat expansions that cause disease.
"It is so important to study genetic variations across different populations. Discovering that the ABCD3 gene was the cause of OPDM in Europeans adds to the understanding of this disease and opens the door for researchers to explore potential treatments for this and similar muscle diseases," Associate Professor Gina Ravenscroft said.
"Identifying disease-causing genes for families is so rewarding, often families experience these life-changing symptoms and many never get answers about the cause of their disorder. For some families this has ended a very long diagnostic odyssey, with DNA samples first received almost 30 years ago."
There are more than 10,000 distinct rare diseases, 70% of which start in childhood. Most of these diseases have a genetic origin, and families must rely on medical researchers to find the disease-gene needle in their DNA haystack.
More on Aussie Journal
- Hiclean Tools Releases HCX2100 Electric Pressure Washer
- Bùng Nổ Ra Mắt, AALIVE Tung Gói Thưởng 68% và Dàn Game Thuần Việt Hấp Dẫn
- ARCH Dental + Aesthetics Offers Free Consultations for New Patients
- Maisano Brothers Inc. Expands National Paving Division Into Tampa, Florida
- Multi-Signature Cold Storage: Keyanb Introduces Institutional-Grade Asset Protection for Chilean Crypto Traders
"Rare diseases impact around 1 in 10 people and these families can go a lifetime without answers. By finding the genetic cause, we can give families a better understanding of the disease progression, their likelihood of passing it on, and importantly it offers the possibility of finding new treatments or cures one day," Associate Professor Ravenscroft said.
The study was published this week in Nature Communications. (https://www.nature.com/articles/s41467-024-49950-2)
Source: Harry Perkins Institute of Medical Research
0 Comments
Latest on Aussie Journal
- Podcast for Midlife Women Entrepreneurs Celebrates 100th Episode with Rhea Lana's Founder and CEO
- What If Help Could Come Before the Fall?
- OddsTrader Examines the NHL Presidents Trophy Curse: Why Regular-Season Success Rarely Leads to Playoff Glory
- Bookmakers Review Launches Betting Insights on NBC's "The Voice: Battle of Champions"
- What is a Vacuum Truck? The Safer Alternative to Traditional Digging
- Coming Up this Weekend on CNBC Mike Milligan Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- UK Website Launches "Toy Time Machine" — Find Your Childhood Christmas Toy in One Click
- $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
- Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
- Thread Advisory Group Launches to Help Retailers Turn Strategy Into Lasting Results
- QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
- Comparing Gastric Bypass and Gastric Sleeve: Dr. Niruben Rajasagaram Explains the Differences
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Childrens Dentist: Advanced Technology for Stress-Free Treatments
- Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications
- Why Preventative HVAC Maintenance Saves You in the Long Run
- Company Loans – Why Timing and Evidence Matter
- White Glove Restoration Sends "Help in Boxes" to Support Communities in Ghana
- NASA Agreements, New Ocean Exploration Applications Added to Partnerships with Defiant Space Corp and Emtel Energy USA for Solar Tech Leader: $ASTI
- Chic and Secure: The Blue Luna Debuts Stylish Keychains with Purpose